- 2012年度
- 大脳皮質の進化の謎に迫る
(2013/03/29) - 活性型ビタミンDで小胞体ストレスを緩和しよう!
(2013/03/29) - Sweat Glands Grown from Newly Identified Stem Cells
(2013/03/29) - ~筋肉の恒常性と健康は相反するものなのか?~ 筋肉においてオートファジーが存在するが故にインスリン抵抗性が存在する
(2013/03/29) - たった1つの因子の抑制で様々な細胞が神経に!?
(2013/03/28) - 乳酸菌を取り込むと、細胞も若返る?! ~"人間、またしても発酵食品のお世話になる"の巻~
(2013/03/27) - 脳腫瘍における新しい遺伝子変異~エピジェネティク
(2013/03/27) - CCR2-dependentrecruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFα
(2013/03/25) - 補体C1qはWntシグナルの活性化を介して細胞を老化させる
(2013/03/19) - Speramtogonial Stem Cell Transplantation into Rhesus Testes Regenerates Spermatogenesis Producing Functional Sperm.
(2013/03/12) - 糖尿病薬剤による抗腫瘍効果
(2013/03/12) - 難病ALSの新たな原因遺伝子の発見
(2013/03/12) - 脊髄損傷にヒートショックプロテインが有効?
(2013/03/11) - 片頭痛患者では血管内皮前駆細胞が少ない?
(2013/03/11) - 筋幹細胞の静止状態はmiRNA-489により維持される
(2013/03/11) - ストレスに弱いってどういうこと?(心の病気にかかるメカニズムの一つ、「ストレス脆弱モデル」をネズミで再現)
(2013/03/09) - 核酸医薬は実現するか~筋強直性ジストロフィー治療の可能性~
(2013/03/09) - なくならないのは技がある!
(2013/03/08) - Down症候群のiPS細胞の染色体数を修正する
(2013/03/08) - 高品質なiPS細胞作製のキーファクターZscan4の同定
(2013/03/08) - Turning off the Neuron Death Pathway
(2013/03/07) - 新しい安全な分子標識-マルチ同位体画像質量分析法-が明らかにした幹細胞の不等分裂様式
(2013/03/07) - 重度脊髄損傷後に移植した神経幹細胞が非常に長く軸索を伸長し、シナプス結合した!
(2013/03/07) - 神経系前駆細胞を元気にして水頭症を治す!?
(2013/03/05) - FUS/TLSとTDP-43 二つのALS原因遺伝子の交差点
(2013/03/01) - 貪食細胞マクロファージが造血幹細胞を優しく包み込んで自己複製能の維持に貢献していた!?
(2013/02/27) - TALENs -新遺伝子改変技術が生命科学を変える!?-
(2013/02/27) - RESTタンパク質による遺伝子発現調節 ~遺伝子発現とシナプス機能~
(2013/02/25) - 腸に住んでいるある平凡な細菌によって大腸がんは引き起こされる!
(2013/02/25) - 癌抑制遺伝子p53の変異はメバロン酸経路を活性化することで、正常な乳腺の構造を失わせる
(2013/02/25) - 樹状細胞は制御性T細胞の恒常性をコントロールすることで多発性硬化症を寛解させる
(2013/02/25) - Schwann Cell Plasticity After Spinal Cord Injury Shown by Neural Crest Lineage Tracing
(2013/02/15) - エクソソームは、癌細胞の「飛び道具」!
(2013/02/08) - 老化したニッチでは筋肉幹細胞は静止状態を保てない
(2013/01/31) - 幹細胞を使った創薬開発
(2013/01/31) - 体細胞リプログラミングにおける遺伝子発現調節の解析からわかること-single cellで見てみようの巻-
(2013/01/31) - がん幹細胞発生のかぎを握るのは誰?-ユーイング肉腫がん幹細胞の解析を通じた検証-
(2013/01/31) - 小動物用PET(Positron Emission Tomography)で、ラットの脳梗塞巣を探知することができる [18F]BMS-PET
(2013/01/31) - 脳の神経ネットワークにおけるヤングパワー!
(2013/01/18) - アストロサイトの性格はどうやって決まる?
(2013/01/18) - 幹細胞の自己複製能を制御する因子とは?
(2013/01/18) - アルデヒドが真犯人!?DNA損傷と再生不良性貧血
(2012/12/18) - HIV-2の新しい定量法
(2012/12/18) - Japanese People's Preference for Place of End-of-Life Care and Death: A Population-Based Nationwide Survey
(2012/12/18) - がん細胞の死に際
(2012/12/18) - 癌幹細胞を眠りから目覚めさせる"Coco"
(2012/12/13) - 細胞接着分子のインテグリンが血液の幹細胞の維持を制御する
(2012/12/11) - 移植された神経幹細胞は免疫系にも作用する
(2012/12/11) - 血液がん克服にむけて!~JAK2阻害剤の薬剤耐性メカニズム解明~
(2012/12/04) - 癌進展を陰で操る支配者
(2012/11/30) - 幹細胞の2つの顔を暴け!!! 未分化性維持と特異的分化との狭間で...
(2012/11/30) - 脊髄損傷後の機能回復には自発的なリハビリが効果的
(2012/11/21) - もしあなたの歯が無くなってしまった時に...
(2012/11/15) - iPS細胞から血小板をつくる
(2012/10/30) - メラノーマのエキソソームで予後予測ができる?!
(2012/10/30) - Oligodendroglia Cells Can Do Much More Than an Insulator for Neuron
(2012/09/11) - APJは、心臓肥大のデュアル受容体として作用する
(2012/09/11) - 幹細胞医療;脳梗塞治療への挑戦
(2012/09/11) - 造血幹細胞の老化と若返り
(2012/09/11) - カロリー制限が筋肉を増やす? - トレーニング界の常識に挑戦する新たな"逆説"
(2012/09/11) - 癌幹細胞は治療標的にならない!?
(2012/08/24) - iPS細胞でC型肝炎ウイルス感染のモデルをつくる
(2012/08/09) - ES細胞、iPS細胞から内耳有毛細胞への分化誘導
(2012/08/09) - 造血幹細胞を冬眠させる細胞はなんと神経系の細胞だった!
(2012/07/06) - 個別化治療への障壁 ~多重人格なガンを克服せよ~
(2012/07/06) - 栄養のバランスが新しいニューロンを作り、体重や新陳代謝をコントロールする
(2012/05/11) - 脊髄不全損傷後におこる、残存神経ネットワークの代償機能
(2012/05/11) - "スーパーPTENマウス"
(2012/04/20) - 統合失調症iPS細胞研究が臨床研究になるために
(2012/04/20) - 発癌機序における"はじめの一歩"
(2012/04/06) - iPS細胞は脊髄損傷を治せるのか?
(2012/04/06)
- 大脳皮質の進化の謎に迫る
- 2011年度
- 2010年度
ホーム > 世界の幹細胞(関連)論文紹介 > Japanese People's Preference for Pl...
Japanese People's Preference for Place of End-of-Life Care and Death: A Population-Based Nationwide Survey
論文紹介著者

リー・アンドリュー・キセイン(博士課程 2年)
GCOE RA
医療政策・管理学教室
第一著者名・掲載雑誌・号・掲載年月
Sakiko Fukui/Journal of Pain and Symptom Management Volume 42 No 6 page 882-892 December 2011
文献の英文表記:著者名・論文の表題・雑誌名・巻・号・ページ・発行年(西暦)
Sakiko Fukui, Kazuhiro Yoshiuchi, Junko Fujita, Minako Sawai, and Minako Watanabe.
Japanese People's Preference for Place of End-of-Life Care and Death: A Population-Based Nationwide Survey. Journal of Pain and Symptom Management 42 6:882-892,2011
論文解説
Where people wish to spend their End-of-Life and die is an important question when developing inpatient and community services. Although the Japanese Ministry of Welfare has conducted 4 national surveys investigating the views of the general public about End-of-Life care over the last 20 years, there is a paucity of published studies in the international literature attempting to determine the preferences of the Japanese population with regard to End-of-Life care. This paper by Fukui et al represents an important addition to the evidence in this field. Fukui et al undertook an anonymous, national postal survey in March 2010 of 2000 Japanese people of 40-79 years of age using a random sampling method. The survey questionnaire asked about people`s preferences for their place of End-of-Life care and their place of death, assuming they had a remaining life expectancy of one to two months, no physical distress, and needed care-assistance in their daily activities. The options for place of End-of-Life care and place of death were hospital, palliative care unit, home, or different types of nursing home. The survey questionnaire also asked questions to assess how people`s preferences varied with their experience, perceptions and knowledge. 1042 completed questionnaires were returned and analyzed (55%.) The results for preferences for place of End-of-Life care and preferences for place of death were very similar, with 65% of respondents choosing the same place to both receive End-of-Life care and to die. For End-of-Life care, 43.7% preferred home, 14.8% preferred an acute hospital, 19.2% preferred a palliative care unit, 9.9% preferred a Heath Care Facility for the Elderly, and 1.6% preferred a private nursing home with 10.8% being uncertain. For death, 42.9% preferred home, 15.7% preferred an acute hospital, 20% preferred a Palliative Care Unit, 7.4% preferred a Health Care Facility for the Elderly, 0.6% preferred a private nursing home, and 13.4% were uncertain.
In their conclusions, Fukui et al state that the rates of preferred End-of-Life care at home and preferred death at home were 44% and 43% respectively in their study, but Ministry of Welfare data for 2008 report only 15% of deaths in Japan occur `at home` (ie out of hospital.) Further, they state that only 15% and 16% respectively of the respondents in their survey wish to receive End-of-Life care in an acute hospital and wish to die in an acute hospital, in contrast to the fact that 85% of Japanese deaths were reported in the 2008 data to occur in hospital.
There are 2 problems with this conclusion. Firstly, the design of this study limits to what extent its results are generalizable. In Japan, only patients with diagnoses of cancer or HIV can be admitted to Palliative Care Units, and so the inclusion of the option of a Palliative Care Unit implies to the responder that in the survey the End-of-Life scenario is a cancer scenario. Indeed, for non-cancer patients the option of a Palliative Care Unit is a meaningless one. Further, it is quite possible preferences for place of End-of-Life care and for place of death are influenced by illness diagnosis. Given the scenario and the options presented, it might be more accurate to consider these survey results specific to respondents` preferences in terminal cancer care rather than generalizing to all End-of-Life care.
The second problem with this conclusion is that the categories are not comparable. Fukui et al ask about `acute hospital` as a place of End-of-Life care or place of death. But the national data to which they make comparisons above report all hospital deaths which will include acute hospital deaths as well as deaths in Long Term Care beds, Rehabilitation beds, Psychiatric beds and of course palliative care beds too. Those expressing a preference to die in acute hospital and those expressing a preference to die in a Palliative Care Unit would both experience a hospital death. Furthermore, the survey allowed an `uncertain` response selected by 13.4% of respondents whereas such a category defies comparison.
Preferences for place of End-of-Life care and for place of death need to be investigated for not just cancer but for all common End-of-Life conditions to best inform policy in this area, and questionnaire tools need to be designed with consideration for the inpatient services for which putative patients would be eligible.

Copyright © Keio University. All rights reserved.